892 related articles for article (PubMed ID: 17250816)
1. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.
Ghosh TK; Mickelson DJ; Fink J; Solberg JC; Inglefield JR; Hook D; Gupta SK; Gibson S; Alkan SS
Cell Immunol; 2006 Sep; 243(1):48-57. PubMed ID: 17250816
[TBL] [Abstract][Full Text] [Related]
2. TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha.
Ghosh TK; Mickelson DJ; Solberg JC; Lipson KE; Inglefield JR; Alkan SS
Int Immunopharmacol; 2007 Aug; 7(8):1111-21. PubMed ID: 17570328
[TBL] [Abstract][Full Text] [Related]
3. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation.
Verreck FA; de Boer T; Langenberg DM; van der Zanden L; Ottenhoff TH
J Leukoc Biol; 2006 Feb; 79(2):285-93. PubMed ID: 16330536
[TBL] [Abstract][Full Text] [Related]
5. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses.
Bohnenkamp HR; Papazisis KT; Burchell JM; Taylor-Papadimitriou J
Cell Immunol; 2007 Jun; 247(2):72-84. PubMed ID: 17927969
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
Kandimalla ER; Bhagat L; Li Y; Yu D; Wang D; Cong YP; Song SS; Tang JX; Sullivan T; Agrawal S
Proc Natl Acad Sci U S A; 2005 May; 102(19):6925-30. PubMed ID: 15860583
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of in vitro tumor cell proliferation by cytokines induced by combinations of TLR or TLR and TCR agonists.
Ghosh TK; Mickelson DJ; Lipson KE; Alkan SS
Int Immunopharmacol; 2007 Nov; 7(11):1471-82. PubMed ID: 17761351
[TBL] [Abstract][Full Text] [Related]
8. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle.
Sukkar MB; Xie S; Khorasani NM; Kon OM; Stanbridge R; Issa R; Chung KF
J Allergy Clin Immunol; 2006 Sep; 118(3):641-8. PubMed ID: 16950283
[TBL] [Abstract][Full Text] [Related]
10. The effect of adenosine receptor agonists on cytokine release by human mononuclear cells depends on the specific Toll-like receptor subtype used for stimulation.
Ramakers BP; Riksen NP; Rongen GA; van der Hoeven JG; Smits P; Pickkers P
Cytokine; 2006 Jul; 35(1-2):95-9. PubMed ID: 16963274
[TBL] [Abstract][Full Text] [Related]
11. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
Merlo A; Calcaterra C; Mènard S; Balsari A
J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
[TBL] [Abstract][Full Text] [Related]
12. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.
Lombardi V; Van Overtvelt L; Horiot S; Moingeon P
J Immunol; 2009 Mar; 182(6):3372-9. PubMed ID: 19265114
[TBL] [Abstract][Full Text] [Related]
13. Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells.
Krumbiegel D; Zepp F; Meyer CU
Hum Immunol; 2007 Oct; 68(10):813-22. PubMed ID: 17961769
[TBL] [Abstract][Full Text] [Related]
14. Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells.
Devilder MC; Allain S; Dousset C; Bonneville M; Scotet E
J Immunol; 2009 Sep; 183(6):3625-33. PubMed ID: 19710464
[TBL] [Abstract][Full Text] [Related]
15. Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids.
Proost P; Verpoest S; Van de Borne K; Schutyser E; Struyf S; Put W; Ronsse I; Grillet B; Opdenakker G; Van Damme J
J Leukoc Biol; 2004 May; 75(5):777-84. PubMed ID: 14996826
[TBL] [Abstract][Full Text] [Related]
16. Combined use of toll-like receptor agonists and prostaglandin E(2) in the FastDC model: rapid generation of human monocyte-derived dendritic cells capable of migration and IL-12p70 production.
Dauer M; Lam V; Arnold H; Junkmann J; Kiefl R; Bauer C; Schnurr M; Endres S; Eigler A
J Immunol Methods; 2008 Sep; 337(2):97-105. PubMed ID: 18657542
[TBL] [Abstract][Full Text] [Related]
17. Interleukin receptor-associated kinase-4 deficiency impairs Toll-like receptor-dependent innate antiviral immune responses.
McDonald DR; Brown D; Bonilla FA; Geha RS
J Allergy Clin Immunol; 2006 Dec; 118(6):1357-62. PubMed ID: 17157666
[TBL] [Abstract][Full Text] [Related]
18. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
[TBL] [Abstract][Full Text] [Related]
19. TLR2 promotes Th2/Th17 responses via TLR4 and TLR7/8 by abrogating the type I IFN amplification loop.
Wenink MH; Santegoets KC; Broen JC; van Bon L; Abdollahi-Roodsaz S; Popa C; Huijbens R; Remijn T; Lubberts E; van Riel PL; van den Berg WB; Radstake TR
J Immunol; 2009 Dec; 183(11):6960-70. PubMed ID: 19915052
[TBL] [Abstract][Full Text] [Related]
20. Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists.
Gorski KS; Waller EL; Bjornton-Severson J; Hanten JA; Riter CL; Kieper WC; Gorden KB; Miller JS; Vasilakos JP; Tomai MA; Alkan SS
Int Immunol; 2006 Jul; 18(7):1115-26. PubMed ID: 16728430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
